Cases 11 - 20 of 75
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FENNEC PHARMACEUTICALS, INC. et al v. CIPLA LIMITED, et al.
as 2:2023cv00123
Plaintiff:
FENNEC PHARMACEUTICALS, INC. and OREGON HEALTH AND SCIENCE UNIVERSITY
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2022cv00162
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Lupin Ltd. et al
as 1:2022cv00615
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Lupin Ltd., Laurus Labs Limited and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Sandoz Inc.
as 22-1147
Cross Appellant:
AMGEN INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Defendant / Appellant:
ZYDUS PHARMACEUTICALS (USA) INC. and SANDOZ INC.
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Sandoz Inc.
as 22-1149
Plaintiff / Appellant:
AMGEN INC.
Defendant / Appellee:
SANDOZ INC., MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD. and others
Amgen Inc. v. Sandoz Inc.
as 22-1150
Cross Appellant:
AMGEN INC.
Defendant / Appellant:
SANDOZ INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
